As of 2026-10-07, the Relative Valuation of BridgeBio Pharma Inc (BBIO) is (83.28) USD. This relative valuation is based on P/E multiples. With the latest stock price at 66.96 USD, the upside of BridgeBio Pharma Inc based on Relative Valuation is -224.4%.
The range of the Relative Valuation is (76.37) - (87.89) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.6x - 27.2x | 22.8x |
| Forward P/E multiples | 21.6x - 24.9x | 24.4x |
| Fair Price | (76.37) - (87.89) | (83.28) |
| Upside | -214.1% - -231.3% | -224.4% |
| Date | P/E |
| 2026-10-01 | -18.94 |
| 2026-09-30 | -18.63 |
| 2026-09-29 | -18.68 |
| 2026-09-28 | -18.86 |
| 2026-09-25 | -18.56 |
| 2026-09-24 | -18.76 |
| 2026-09-23 | -18.60 |
| 2026-09-22 | -19.60 |
| 2026-09-21 | -18.85 |
| 2026-09-18 | -18.86 |
| 2026-09-17 | -19.05 |
| 2026-09-16 | -19.34 |
| 2026-09-15 | -19.36 |
| 2026-09-14 | -20.49 |
| 2026-09-11 | -20.51 |
| 2026-09-10 | -20.52 |
| 2026-09-09 | -21.54 |
| 2026-09-08 | -21.16 |
| 2026-09-04 | -21.19 |
| 2026-09-03 | -21.35 |
| 2026-09-02 | -21.66 |
| 2026-09-01 | -21.68 |
| 2026-08-31 | -21.68 |
| 2026-08-28 | -21.68 |
| 2026-08-27 | -22.27 |
| 2026-08-26 | -22.47 |
| 2026-08-25 | -22.76 |
| 2026-08-24 | -22.95 |
| 2026-08-21 | -23.07 |
| 2026-08-20 | -23.48 |
| 2026-08-19 | -23.77 |
| 2026-08-18 | -23.49 |
| 2026-08-17 | -22.62 |
| 2026-08-14 | -22.61 |
| 2026-08-13 | -22.99 |
| 2026-08-12 | -23.73 |
| 2026-08-11 | -23.69 |
| 2026-08-10 | -23.97 |
| 2026-08-07 | -23.92 |
| 2026-08-06 | -23.44 |
| 2026-08-05 | -23.21 |
| 2026-08-04 | -23.23 |
| 2026-08-03 | -22.64 |
| 2026-07-31 | -22.67 |
| 2026-07-30 | -23.25 |
| 2026-07-29 | -23.65 |
| 2026-07-28 | -24.22 |
| 2026-07-27 | -23.81 |
| 2026-07-24 | -23.79 |
| 2026-07-23 | -23.48 |